Principal Financial Group Inc Bridge Bio Pharma, Inc. Transaction History

Principal Financial Group Inc

$167 Billion
Q1 2025

A detailed history of Principal Financial Group Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 1,148,292 shares of BBIO stock, worth $43.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,148,292

Previous 1,050,139 9.35%

Holding current value

$43.1 Million

Previous $28.8 Million 37.76%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	BUY	$28.12 - $37.59 $2.76 Million - $3.69 Million	98,153 Added 9.35%	1,148,292 $39.7 Million
Q4 2024 Jan 31, 2025	BUY	$22.35 - $29.5 $23.5 Million - $31 Million	1,050,139 New	1,050,139 $28.8 Million
Q3 2024 Oct 31, 2024	BUY	$23.91 - $31.3 $477,673 - $625,311	19,978 Added 1.78%	1,145,123 $29.2 Million
Q2 2024 Jul 29, 2024	BUY	$23.0 - $31.04 $1.2 Million - $1.61 Million	51,958 Added 4.84%	1,125,145 $28.5 Million
Q1 2024 Apr 29, 2024	BUY	$27.35 - $40.45 $3.55 Million - $5.25 Million	129,703 Added 13.75%	1,073,187 $33.2 Million
Q4 2023 Feb 07, 2024	BUY	$24.02 - $43.89 $4.75 Million - $8.68 Million	197,818 Added 26.53%	943,484 $38.1 Million
Q3 2023 Nov 02, 2023	BUY	$16.89 - $35.01 $11.9 Million - $24.7 Million	705,249 Added 1744.93%	745,666 $19.7 Million
Q2 2023 Aug 07, 2023	BUY	$13.29 - $18.01 $92,312 - $125,097	6,946 Added 20.75%	40,417 $695,000
Q1 2023 May 09, 2023	BUY	$7.17 - $18.55 $3,398 - $8,792	474 Added 1.44%	33,471 $554,000
Q4 2022 Feb 09, 2023	BUY	$6.74 - $11.52 $16,027 - $27,394	2,378 Added 7.77%	32,997 $251,000
Q3 2022 Nov 09, 2022	BUY	$7.94 - $12.36 $15,141 - $23,570	1,907 Added 6.64%	30,619 $305,000
Q2 2022 Aug 10, 2022	SELL	$5.21 - $12.14 $22,772 - $53,063	-4,371 Reduced 13.21%	28,712 $260,000
Q1 2022 May 09, 2022	SELL	$7.34 - $17.16 $2,018 - $4,719	-275 Reduced 0.82%	33,083 $336,000
Q4 2021 Feb 09, 2022	SELL	$11.38 - $53.41 $168,606 - $791,322	-14,816 Reduced 30.76%	33,358 $556,000
Q3 2021 Nov 09, 2021	SELL	$46.87 - $64.24 $107,519 - $147,366	-2,294 Reduced 4.55%	48,174 $2.26 Million
Q2 2021 Aug 10, 2021	BUY	$46.47 - $63.93 $135,785 - $186,803	2,922 Added 6.15%	50,468 $3.08 Million
Q1 2021 May 10, 2021	BUY	$55.47 - $72.35 $214,058 - $279,198	3,859 Added 8.83%	47,546 $2.93 Million
Q4 2020 Feb 08, 2021	BUY	$38.38 - $71.11 $264,016 - $489,165	6,879 Added 18.69%	43,687 $3.11 Million
Q3 2020 Nov 06, 2020	SELL	$27.2 - $42.19 $53,203 - $82,523	-1,956 Reduced 5.05%	36,808 $1.38 Million
Q2 2020 Aug 05, 2020	BUY	$22.22 - $35.69 $659,045 - $1.06 Million	29,660 Added 325.79%	38,764 $1.26 Million
Q1 2020 May 12, 2020	BUY	$16.11 - $36.23 $146,665 - $329,837	9,104 New	9,104 $264,000

Others Institutions Holding BBIO

# of Institutions

362

Shares Held

185M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.56B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Bridge Bio Pharma, Inc. Transaction History